Bazan V

No ORCID on file · 2 papers in corpus

review 2026

Cancer-associated mutations in endometriosis reframe a benign disease through molecular oncology

Molecular oncology ·doi:10.1002/1878-0261.70295

Endometriosis is a benign yet debilitating condition, and its molecular complexity remains unexplored. Although clinically recognized, its genetic landscape has long been overlooked. This review analyses cancer-associated mutations (CAMs) i…

2022

Can circulating PD-1, PD-L1, BTN3A1, pan-BTN3As, BTN2A1 and BTLA levels enhance prognostic power of CA125 in patients with advanced high-grade serous ovarian cancer?

Frontiers in oncology ·doi:10.3389/fonc.2022.946319

The most common subtype of ovarian cancer (OC) is the high-grade serous ovarian carcinoma (HGSOC), accounting for 70%-80% of all OC deaths. Although HGSOC is a potentially immunogenic tumor, clinical studies assessing the effectiveness of i…